Cargando…
New era of personalised epilepsy management
The trial and error approach to epilepsy treatment has not changed for over a century but machine learning and patient derived stem cells promise a personalised and more effective strategy, argue Patrick Kwan and colleagues
Autores principales: | Chen, Zhibin, Rollo, Ben, Antonic-Baker, Ana, Anderson, Alison, Ma, Yuanlin, O’Brien, Terence J, Ge, Zongyuan, Wang, Xuefeng, Kwan, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541035/ https://www.ncbi.nlm.nih.gov/pubmed/33037001 http://dx.doi.org/10.1136/bmj.m3658 |
Ejemplares similares
-
Applications for Deep Learning in Epilepsy Genetic Research
por: Zeibich, Robert, et al.
Publicado: (2023) -
Human In Vitro Models of Epilepsy Using Embryonic and Induced Pluripotent Stem Cells
por: Javaid, Muhammad Shahid, et al.
Publicado: (2022) -
Personalised nutrition and health
por: Ordovas, Jose M, et al.
Publicado: (2018) -
The effects of cell therapy on seizures in animal models of epilepsy: protocol for systematic review and meta-analysis of preclinical studies
por: Dvir, Naomi, et al.
Publicado: (2019) -
Incidence and risk factors of posttraumatic epilepsy following pediatric traumatic brain injury: A systematic review and meta‐analysis
por: Mariajoseph, Frederick P., et al.
Publicado: (2022)